Telehealth Depression Prescribing: What Psychiatric NPs Can Do in Florida

If you’re a psychiatrist or psychiatric nurse practitioner wondering whether you can treat depression via telehealth — and prescribe the medications patients actually need — here’s the short answer: Yes, you can. But the how depends on your credentials, your state’s rules, and whether you understand the current regulatory landscape.

Let’s cut through the confusion. Depression is one of the most common conditions you’ll treat in telepsychiatry, and medication management for depression fits telehealth perfectly. Most antidepressants are non-controlled substances, which means you sidestep the DEA headaches that come with prescribing stimulants or benzodiazepines. Even when you do need to prescribe a controlled adjunct — say, a benzo for severe anxiety or a sleep aid — temporary federal waivers allow tele-prescribing through at least the end of 2025, with permanent rules expected soon.

But here’s where it gets state-specific: your prescribing authority varies dramatically depending on whether you’re an MD/DO psychiatrist or a PMHNP, and which state you’re licensed in. A psychiatrist has full independent authority everywhere. A PMHNP? It depends. In New York, you’re practicing independently after 3,600 hours of experience. In Texas or Florida, you need a supervising physician to prescribe anything — even an SSRI.

This guide breaks down exactly what you can do, where you can do it, and how telehealth reimbursement actually works for medication management. Whether you’re considering joining a platform like Klarity Health or expanding your existing practice, you need to know the rules that govern your ability to treat depression remotely.

What Depression Prescribing Looks Like in Telehealth

Managing depression via telehealth mirrors in-person care in most ways that matter. You conduct a psychiatric evaluation over video, assess symptoms (PHQ-9 scores, functional impairment, suicide risk), formulate a diagnosis, and initiate treatment. For medication management, you’re typically prescribing:

• SSRIs/SNRIs (sertraline, escitalopram, venlafaxine, duloxetine)
• Atypical antidepressants (bupropion, mirtazapine)
• Augmenting agents (aripiprazole, brexanolone for severe cases)
• Occasionally controlled substances for comorbid conditions (benzodiazepines for panic disorder, stimulants for depression with ADHD, sleep aids)

The workflow is straightforward: after your video session, you e-prescribe to the patient’s local pharmacy. You schedule follow-ups — often every 2–4 weeks initially to monitor response and side effects, then monthly or longer once stable. Since you’re not doing hour-long therapy sessions, you can structure 15–30 minute medication checks that allow you to see more patients efficiently.

The clinical advantage of telehealth for depression: You can do frequent brief check-ins during the critical first 8–12 weeks of antidepressant trials, which improves adherence and catches side effects early. Patients appreciate not having to take time off work or arrange transportation for a 20-minute med check. You get better continuity of care.

What you need in place:

• State medical/nursing license where the patient is physically located during the visit
• DEA registration in that state (for controlled substances, if applicable)
• Telehealth platform that’s HIPAA-compliant with secure video (Klarity provides this)
• E-prescribing setup integrated with state prescription monitoring programs (PDMPs)
• Malpractice insurance that covers telemedicine practice

Most telehealth platforms handle the infrastructure — EHR, video conferencing, e-prescribing, billing support. Your job is the clinical work.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Psychiatrists: You Have Full Prescribing Authority (With State Licensing Caveats)

If you’re a psychiatrist (MD or DO), you can prescribe any medication for depression via telehealth without supervision or collaborative agreements. Your medical license grants full prescriptive authority in every state. There are no disease-specific scope limitations — depression falls squarely within your practice domain.

What this means practically:

• You can initiate antidepressants for new patients after a video evaluation (no in-person visit required for non-controlled meds)
• You can adjust medications, switch treatments, add augmenting agents
• You can prescribe controlled substances (benzodiazepines, stimulants, sleep aids) when clinically indicated, following current federal telemedicine prescribing rules
• You can order labs if needed (TSH to rule out hypothyroidism, metabolic panels before starting certain meds) with patients getting bloodwork done locally
• You have no supervisory tether — you answer only to your medical license and standard of care requirements

The Licensing Reality

The catch isn’t your scope — it’s geography. You must be licensed in the state where the patient is located during the telehealth session. Most states still require full licensure for out-of-state telemedicine (no temporary COVID waivers remaining for this in most places).

Good news: The Interstate Medical Licensure Compact (IMLC) provides an expedited pathway to multi-state licensure. As of 2026, 37 states participate in the Compact, allowing physicians to obtain licenses in multiple states through a streamlined process. For example, if you’re licensed in Texas and want to treat patients in Illinois, Florida, and Pennsylvania via telehealth, the Compact can fast-track those additional licenses.

Strategy for telepsychiatrists: Obtain licenses in 3–5 states with high demand and complementary markets. Texas and Florida have severe psychiatrist shortages (ratios around 1:8,500–9,000 residents), meaning consistent patient volume. New York has better supply in cities but rural shortages. By holding multiple state licenses, you dramatically expand your potential patient base on a platform like Klarity.

Controlled Substance Prescribing

Here’s where federal rules intersect with your practice. The Ryan Haight Act normally requires an in-person medical evaluation before prescribing controlled substances via telemedicine. But during COVID-19, the DEA waived this requirement for all Schedule II–V medications prescribed via telemedicine.

Current status (as of early 2025): The DEA has extended these telemedicine prescribing flexibilities through December 31, 2025. This means you can legally prescribe controlled medications (benzodiazepines, stimulants, certain sleep aids) via telehealth nationwide under the temporary rule, as long as you conduct a proper audio-video evaluation.

The DEA has proposed new permanent telemedicine prescribing regulations that would allow for certain telehealth prescribing of controlled substances without an initial in-person visit, with special provisions for mental health treatment. These rules are expected to be finalized by late 2025, providing a clear long-term framework.

What you need to do:

• Have a valid DEA registration in the state where you’re prescribing
• Conduct a thorough evaluation via live audio-video (asynchronous or phone-only doesn’t qualify)
• Document the clinical rationale for prescribing the controlled substance
• Follow state-specific PDMP requirements (checking prescription drug monitoring programs before prescribing)
• Stay updated on final DEA rules when they publish

For depression specifically: Most first-line treatments (SSRIs, SNRIs, bupropion, mirtazapine) are non-controlled, so you don’t encounter these restrictions at all. You only deal with controlled substance rules when treating comorbid anxiety (benzodiazepines), severe insomnia (zolpidem, eszopiclone), or depression with ADHD (stimulants) — and even then, current federal policy allows it.

Reimbursement for Psychiatrist Telehealth Visits

You’re billing the same evaluation and management (E/M) codes via telehealth as you would in-person:

• 99213 (15-minute established patient visit, low complexity): ~$80–100
• 99214 (25–30 minute visit, moderate complexity): ~$120–130
• 99215 (40+ minute visit, high complexity): ~$160–180
• Initial psychiatric evaluations (90792 or longer E/M codes): ~$200–300

Thanks to telehealth parity laws in most states, insurers reimburse these codes at the same rate as in-person visits. As of 2025, 44 states plus DC mandate some form of telehealth coverage, and 23 states explicitly require equal payment for virtual visits. Among priority states:

• New York, Illinois, California, Pennsylvania: Strong parity laws ensuring equal reimbursement
• Texas: Partial parity (Medicaid pays at parity; many private insurers follow suit)
• Florida: Coverage parity but not always payment parity mandated; in practice, major insurers pay comparably for tele-mental health

Medicare: Pays telehealth mental health visits at the same rate as in-person through at least September 30, 2025 (and likely to be extended further given bipartisan support). Medicare also waived the requirement for an in-person visit within 6 months of tele-mental health services. You can bill standard E/M codes for medication management at full Medicare rates (e.g., ~$115 for 99214).

What this means economically: A psychiatrist doing medication management via telehealth can see 4–6 patients per hour (depending on complexity) and generate $400–600+ in billable services hourly. Compare that to traditional office overhead, commute time, and geographic patient limitations — telehealth is often more profitable per clinical hour.

Platform models: Many telepsychiatry platforms (like Klarity) operate on a per-appointment fee structure rather than taking a percentage of your collections. This means you pay a standard fee per new patient lead or per completed visit, but you keep the insurance reimbursement or patient payment. This is economically cleaner than traditional fee splits and removes the headache of credentialing, billing, and collections.

PMHNPs: Your Authority Depends Entirely on Your State

If you’re a Psychiatric Mental Health Nurse Practitioner, your ability to prescribe depression medications via telehealth hinges on which state you’re licensed in and whether that state grants full, reduced, or restricted practice authority.

The Three Tiers of NP Practice Authority

Full Practice Authority: You can evaluate, diagnose, and prescribe independently — no physician oversight required. States include New York, California (starting 2026 for most experienced NPs), and about 25 other states nationwide.

Reduced Practice Authority: You can practice with some independence but need a collaborative agreement with a physician for prescribing or certain clinical decisions. States include Pennsylvania, Illinois (unless you obtain FPA certification after 4,000 hours).

Restricted Practice Authority: You must have continuous physician supervision or delegation for all practice, including prescribing. States include Texas, Florida (for psychiatric NPs), and a shrinking number of others.

State-by-State Breakdown for PMHNPs Treating Depression

New York — Full Independence:
New York is a full practice state as of 2022. After completing 3,600 hours of clinical practice (roughly 1.5–2 years full-time), PMHNPs can practice and prescribe without a collaborative agreement or physician supervision.

What you can do: Evaluate patients, diagnose major depressive disorder, prescribe SSRIs/SNRIs and other antidepressants, manage medication trials, order labs — all independently. You need your own DEA registration to prescribe controlled substances (if treating comorbid anxiety with benzos, for example), but no physician sign-off is required.

Telehealth: No special restrictions. As long as you’re licensed in New York and the patient is in New York during the visit, you’re practicing within full scope.

Economics: New York pays NPs well, though Medicare reimburses at 85% of the physician rate (more on that below). Private insurance typically pays at parity for behavioral health services.

Pennsylvania — Collaborative Agreement Required:
Pennsylvania is a reduced practice state. PMHNPs must maintain a collaborative agreement with a physician to prescribe medications. The physician doesn’t need to co-sign each prescription, but the agreement must outline your scope of practice and the physician’s availability for consultation.

What this means: You can independently conduct evaluations and prescribe antidepressants, but legally, you’re operating under a collaborative framework. The physician must be available for case discussions, and a certain percentage of your charts may need physician review (exact requirements vary by agreement).

For telehealth platforms: The platform needs to arrange or facilitate this collaborative relationship. If you join Klarity Health and want to see Pennsylvania patients, Klarity would either need to employ a supervising psychiatrist willing to collaborate with you, or you’d need to bring your own collaborative agreement.

Recent developments: Pennsylvania passed Act 68 of 2021, which created a pathway for NPs to gain independent prescriptive authority after a mentorship period. However, as of 2026, the state remains categorized as Reduced Practice by AANP because the transition is still rolling out. Long-term, expect Pennsylvania to move toward full practice.

Illinois — Reduced Practice with FPA Pathway:
Illinois is officially a reduced practice state, but experienced NPs can apply for Full Practice Authority (FPA) status after completing 4,000 hours of clinical practice under a collaborative agreement plus additional training.

If you have FPA certification: You can practice without a written collaborative agreement in your specialty area (psychiatric mental health). You can independently prescribe most depression medications. However, Illinois law still requires you to have a consultation relationship with a physician for prescribing certain controlled substances like benzodiazepines or Schedule II stimulants. This doesn’t mean formal supervision — often just a documented consultation protocol.

If you don’t have FPA: You need a written collaborative agreement with a physician to prescribe anything, including non-controlled antidepressants.

Practical reality: Many Illinois PMHNPs treating depression have FPA status and operate quite independently for standard medication management (SSRIs, SNRIs, bupropion). When you need to prescribe a benzo or adjunct stimulant, you consult with your collaborating MD (often just a phone call or chart note) but don’t need co-signature.

Telehealth: Illinois has strong telehealth coverage and parity laws. No special barriers for NPs doing tele-mental health as long as collaborative requirements are met.

California — Transitioning from Restricted to Full Practice:
California was historically one of the most restrictive states for NPs — you needed ‘standardized procedures’ developed with a supervising physician for almost everything. AB 890 (passed in 2020) is changing that in phases.

Current status (2025–2026):

• Since January 2023: ‘Category 103’ NPs who meet education and experience requirements can practice without standardized procedures in group settings (clinics, hospitals, healthcare facilities) without physician supervision.
• Starting January 2026: ‘Category 104’ NPs can practice independently in any setting (including private practice and telehealth companies) once they obtain special certification from the California Board of Nursing.

Requirements: Typically a master’s degree or doctorate in psychiatric nursing, national certification (PMHNP-BC), and ~3 years (or more) of supervised practice.

What this means for depression prescribing:
By 2026, a qualified PMHNP in California can evaluate and prescribe for depression without a physician’s sign-off, even in a telehealth-only practice. You can prescribe antidepressants, manage medication trials, order labs — essentially function like a psychiatrist within your scope.

If you’re not yet certified under the new law: You still need a supervising physician and standardized procedures. But the trend is clear: California is moving toward parity with MD authority for experienced NPs.

Telehealth: California has strong telehealth coverage laws and parity provisions. Once you have independent certification, you’re free to practice telepsychiatry across California without physician oversight.

Texas — Strict Supervision Required:
Texas is one of the most restrictive states for NPs. You must practice under a formal Prescriptive Authority Agreement with a physician. The supervising physician must conduct regular chart reviews (state law specifies a percentage of charts), and you must have periodic face-to-face meetings.

What this means: You cannot prescribe any medication — including non-controlled SSRIs — unless a delegating physician has signed an agreement and is actively overseeing your practice. The physician doesn’t have to be on-site, but they must be engaged.

Controlled substances: Texas generally does not allow NPs to prescribe Schedule II medications in outpatient settings (except in hospital-based or hospice settings). You can prescribe Schedule III–V (like benzodiazepines or certain sleep aids) under your agreement, but Schedule II stimulants (for ADHD comorbid with depression) are off-limits.

Legislative attempts: In 2023, Texas introduced SB 1700 (the ‘HEAL Texans Act’) to grant NPs full practice authority, citing the severe provider shortage (Texas has ~1 psychiatrist per 8,966 residents — one of the worst ratios in the country). The bill did not pass. As of 2026, Texas remains a Restricted Practice state.

For telehealth: The supervision requirements still apply even if you’re practicing via telemedicine. A telehealth platform operating in Texas would need to provide physician oversight for any PMHNP seeing Texas patients.

Reality check: Texas’s restrictive laws are frustrating given the massive shortage of mental health providers. But until legislation changes, psychiatrists have a clear operational advantage in Texas — they can practice independently, while NPs are tethered.

Florida — Partial Autonomy for Primary Care, Not Psych:
Florida updated its NP laws in 2020 to create a category of autonomous practice — but it’s limited to primary care specialties (family medicine, pediatrics, internal medicine) and midwifery. Psychiatric NPs were explicitly excluded.

What this means: PMHNPs in Florida must still practice under a written protocol with a supervising physician. The protocol outlines your scope of practice and prescriptive authority. The supervising physician must review a percentage of your charts and be available for consultation.

Controlled substances: Florida allows NPs to prescribe Schedule II–V drugs under their protocol, but with some limits. For example:

• Schedule II prescriptions for acute pain are capped at a 7-day supply
• NPs cannot prescribe controlled substances for chronic non-cancer pain (with exceptions)
• PMHNPs, as psychiatric specialists, can prescribe benzodiazepines or stimulants to adults when the supervising physician delegates that authority

Telehealth: Florida has telehealth parity laws for coverage (though not always payment parity mandated). No special restrictions on tele-prescribing of non-controlled meds. For controlled substances via telehealth, you follow federal rules (currently permissive under DEA extensions) plus your protocol requirements.

Market context: Florida has a severe psychiatrist shortage (ratio ~1:8,577 residents) and a large, aging population with depression. There’s huge demand for telepsychiatry services. But the restricted NP scope means platforms need to involve psychiatrists to supervise NP practice.

The Medicare Reimbursement Difference

One economic factor to understand: Medicare pays PMHNPs at 85% of the physician fee schedule when services are billed under the NP’s NPI. For example:

• If a psychiatrist bills 99214 and receives $115 from Medicare, an NP billing the same code receives ~$98.
• For a 99213, if an MD gets $80, an NP gets ~$68.

This is federal law (42 CFR 414) and applies nationwide. Private insurers often pay NPs at full parity for behavioral health services, but Medicare does not.

What this means for you: If you’re an NP treating Medicare patients via telehealth, you’ll earn slightly less per visit than a psychiatrist. It’s not a dealbreaker — 85% is still reasonable pay — but it’s a consideration when evaluating platform economics or fee structures.

For platforms: This is why some telehealth companies structure NP compensation differently from MD compensation, or why they might focus recruiting on states where NPs have full practice authority (to maximize efficiency without physician oversight costs).

The Economics of Telehealth Depression Care: Patient Acquisition and Revenue

Let’s talk about the business model, because joining a telehealth platform isn’t just about clinical work — it’s about whether you can build a sustainable income stream without gambling on expensive marketing.

The DIY Marketing Reality

If you’re thinking of building your own telehealth depression practice independently, here’s what patient acquisition actually costs:

SEO (Search Engine Optimization): Takes 6–12 months of consistent investment before generating meaningful patient flow. You need a website, content, backlinks, local SEO — realistically $2,000–5,000/month if you hire an agency, or hundreds of hours if you do it yourself. And you compete with every other provider in your market.

Google Ads: Mental health keywords are expensive. Terms like ‘depression psychiatrist near me’ or ‘online therapy for depression’ cost $15–40+ per click. Most clicks don’t convert to booked patients. A realistic cost per booked patient through PPC is $200–400+ when you factor in click costs, landing page optimization, and conversion rates.

Psychology Today and Directory Listings: Psychology Today charges monthly fees ($30–40/month) and you’re competing with hundreds of other providers on the same search page. Zocdoc charges per booking ($35–100+ per appointment) plus monthly subscription fees. Add it all up and total monthly cost can easily hit $500–1,000+ for uncertain patient volume.

Total monthly investment: If you’re running SEO, Google Ads, and directory listings simultaneously, expect $3,000–5,000/month in marketing spend with no guarantee of ROI — especially in the first 6–12 months while you build momentum.

Staff time and failed campaigns: You also need someone to handle leads, answer calls, qualify patients, and manage no-shows from cold leads. Failed campaigns (which are common — most marketing experiments don’t work) are sunk costs.

Reality check: DIY marketing can be cost-effective if you have the budget, expertise, and patience. But for most providers — especially those starting out or scaling — it’s a gamble.

The Platform Model: Pay-Per-Appointment Economics

Platforms like Klarity Health use a pay-per-appointment model that fundamentally changes the economics:

• No upfront marketing spend: The platform handles patient acquisition through SEO, paid ads, partnerships, and brand marketing.
• No monthly subscription fees: You don’t pay unless you see patients.
• Pre-qualified patients: Klarity matches patients to your specialty and availability — you’re not fielding unqualified leads.
• Standard fee per new patient: You pay a listing fee per new patient lead (similar to Zocdoc’s model). Exact amounts vary, but it’s typically structured so you’re profitable after 1–2 visits with that patient.
• Built-in infrastructure: Telehealth platform, EHR, e-prescribing, billing support, HIPAA compliance — no separate software costs.
• Insurance and cash-pay mix: Klarity works with both insurance patients (who reimburse you at standard rates) and cash-pay patients (who pay out-of-pocket, often at higher rates).
• You control your schedule: Set your availability, accept or decline patients, scale up or down as you want.

The economic case:
Instead of spending $3,000–5,000/month on marketing with uncertain results, you pay only when a qualified patient books with you. That’s guaranteed ROI — if a patient doesn’t materialize, you haven’t spent anything.

For example:

• New patient evaluation (60 minutes): Insurance reimburses ~$250, you pay $X listing fee, net ~$150–200 profit
• Follow-up visits (20–30 minutes): Insurance reimburses ~$120–130, minimal platform fees, net ~$100–120 profit
• After 2–3 visits with each patient, you’ve recouped any initial listing fee and you’re profitable on ongoing care

Compare that to the provider who spent $4,000 on Google Ads and got 5 qualified patients that month (effective CAC of $800 per patient) — and that’s only if the campaigns worked.

The efficiency advantage: You focus on clinical work. The platform handles marketing, patient acquisition, scheduling infrastructure, and administrative overhead. You see more patients per hour of your time because you’re not managing the business apparatus.

Key Considerations Before Joining a Telehealth Platform

1. Multi-State Licensing

To maximize your earning potential, get licensed in 3–5 high-demand states. Use the Interstate Medical Licensure Compact (IMLC) if you’re a physician to streamline the process. States with strong demand for depression treatment include:

• Texas (severe shortage, 1:9k psychiatrist ratio)
• Florida (aging population, 1:8.5k ratio)
• California (large population, mixed demand)
• New York (rural shortages despite good urban supply)
• Pennsylvania, Illinois (moderate shortages in certain regions)

If you’re an NP, prioritize full practice states (New York, soon California) to avoid collaborative agreement complications.

2. Credentialing and Insurance Panels

Most telehealth platforms handle insurance credentialing for you, but understand the timeline: credentialing takes 90–180 days with major insurers. During that period, you might see cash-pay patients only.

Ask the platform:

• Which insurance networks are they in-network with?
• Do they handle credentialing, or do you manage it yourself?
• What’s the payer mix (commercial insurance vs Medicare vs Medicaid vs cash-pay)?

Ideal scenario: The platform is credentialed with major commercial insurers (Aetna, BCBS, UnitedHealthcare) in your licensed states, and they handle enrolling you under their group NPI or facilitate individual credentialing.

3. Revenue Per Patient Model

Understand exactly how you’re compensated:

• Per-appointment fee (you pay a set amount per patient, keep insurance reimbursement)
• Revenue share (platform takes a percentage of collections)
• Salary/hourly (you’re paid a salary regardless of patient volume)
• Hybrid (base salary plus per-patient bonuses)

Per-appointment or revenue share models tend to align better with provider autonomy — you’re essentially running your own practice with platform support. Salary models offer more stability but less upside.

Calculate your effective hourly rate under different scenarios:

• If you see 3 patients/hour at $120 reimbursement each = $360/hour gross
• Subtract platform fees, taxes, malpractice insurance
• Compare to traditional employment ($150–250/hour for psychiatrists, $80–150/hour for NPs)

4. Patient Volume and Quality

Ask the platform:

• What’s the average patient volume for new providers?
• How many hours per week do I need to commit to maintain patient flow?
• What’s the typical patient severity mix (mild depression vs treatment-resistant)?
• What’s the no-show rate (telehealth generally has lower no-shows, ~10–15% vs 20–30% in-person)?
• Can I set my own appointment limits and availability?

Red flag: If the platform can’t give you data on average patient volume or provider earnings, they may not have enough patients to support consistent work.

5. Scope of Practice and Clinical Autonomy

Confirm:

• Are there formulary restrictions (e.g., platform policies limiting certain medications)?
• Can you treat patients across the diagnostic spectrum (depression, anxiety, ADHD, bipolar) or only specific conditions?
• What’s the process for referring patients who need higher-level care (hospitalization, intensive outpatient)?
• Do you have access to clinical support (peer consultation, supervision for complex cases)?

For NPs in reduced/restricted practice states: Clarify exactly how the platform provides physician collaboration. Is there a psychiatrist on staff available for consultation? Do you need to bring your own collaborative agreement?

FAQs: Depression Prescribing via Telehealth

Can I prescribe antidepressants to a new patient after just a video visit, or do I need an in-person exam first?

For non-controlled medications (SSRIs, SNRIs, bupropion, mirtazapine), you can prescribe after a proper telehealth evaluation — no in-person visit required. Most states and insurers consider a synchronous audio-video evaluation as sufficient to establish a patient-provider relationship for prescribing. For controlled substances (benzodiazepines, stimulants), federal DEA rules are currently permissive through end of 2025 under temporary waivers, allowing tele-prescribing without initial in-person visits. Permanent rules are expected by late 2025.

Do I need separate DEA registrations for each state where I practice telehealth?

Yes, if you’re prescribing controlled substances. You need a DEA registration in each state where you’re prescribing controlled meds (even if the patient is in a different state from where you’re physically located — you need it in the patient’s state). For non-controlled antidepressants, DEA registration isn’t required at all.

How does reimbursement for telehealth compare to in-person visits?

In most states, telehealth parity laws ensure equal reimbursement. As of 2025, 44 states mandate telehealth coverage and 23 explicitly require payment parity. Medicare pays telehealth mental health visits at the same rate as in-person through at least late 2025. Expect typical reimbursement of $80–100 for a 15-minute med check (99213), $120–130 for a 30-minute visit (99214), and $200–300 for initial evaluations.

What if I want to treat patients in multiple states?

You need a medical or nursing license in each state where your patients are located during telehealth visits. Psychiatrists can use the Interstate Medical Licensure Compact (IMLC) to streamline multi-state licensing in 37 participating states. NPs need to apply for licensure state-by-state (no multi-state compact for NPs that covers prescribing authority broadly).

As a PMHNP, do I need a collaborating physician in every state?

It depends on each state’s scope of practice laws. In full practice states (New York, soon California for experienced NPs), you do not need a collaborating physician. In reduced/restricted practice states (Texas, Florida, Pennsylvania, Illinois without FPA), you need a collaborative agreement or supervision per that state’s law — even for telehealth.

Can I prescribe buprenorphine for depression patients with opioid use disorder via telehealth?

Yes. The DEA’s telemedicine flexibilities allow prescribing buprenorphine (a Schedule III controlled substance) via telehealth through end of 2025 without an initial in-person visit. You need an X-waiver (now called DATA 2000 waiver, recently simplified) to prescribe buprenorphine. This is relevant if you’re treating patients with comorbid depression and substance use disorder.

What happens if a patient I’m treating via telehealth becomes suicidal?

You follow the same crisis protocols as in-person care: conduct a thorough suicide risk assessment, develop a safety plan, consider involving emergency services (988 Suicide & Crisis Lifeline, local mobile crisis teams, or 911 if imminent danger). Have local emergency contacts for each state where you practice. Most telehealth platforms have protocols for emergency situations, including connecting patients to local crisis resources. Document thoroughly.

The Bottom Line: Telehealth Depression Care Is Viable, Reimbursed, and Growing

Treating depression via telehealth works — clinically, legally, and economically. The regulatory environment has stabilized post-pandemic with most telehealth flexibilities extended or made permanent. Reimbursement is at parity with in-person care in most states. Patient demand is sustained (behavioral health telehealth remains 20+ times higher than pre-2019 levels).

For psychiatrists: You have full prescriptive authority everywhere. Focus on obtaining multi-state licenses to maximize your reach. Join a platform that handles patient acquisition and administrative overhead so you can focus on clinical work.

For PMHNPs: Your authority depends on your state. If you’re in a full practice state (or will be by 2026 in California), you have nearly the same autonomy as a psychiatrist. If you’re in a reduced or restricted practice state, make sure the platform provides physician collaboration infrastructure.

The economic case for platforms like Klarity Health: Instead of spending thousands per month on uncertain marketing, you pay only when qualified patients book with you. The platform handles acquisition, infrastructure, and administrative burden. You control your schedule and scale at your own pace. It’s guaranteed ROI vs gambling on DIY marketing.

Depression treatment via telehealth isn’t a temporary trend or regulatory loophole — it’s the new standard of care for millions of patients who need access to psychiatric medication management but can’t easily get to an office. If you’re a qualified provider sitting on the sidelines wondering whether telepsychiatry is legitimate, profitable, or sustainable: it is. The question is whether you’re going to build that practice yourself (expensive, slow) or leverage a platform that’s already solved patient acquisition (immediate, low-risk).

If you want more patients, less administrative headache, and the flexibility to practice from anywhere, exploring a telehealth platform is worth your time.

Sources and References

1. California AB 890 Full Text – California Legislature official site. Sept 29, 2020 (law approval); in effect 2023–2026. https://www.leginfo.legislature.ca.gov/faces/billTextClient.xhtml?bill_id=201920200AB890

2. Florida Board of Nursing / FLANP summary of HB607 and NP practice laws. Law effective July

Source:

• https://www.jdsupra.com/legalnews/new-law-allows-experienced-nps-to-8292796/#:~:text=New%20York%E2%80%99s%202023%20state%20budget%2C,practice%20without%20a%20collaborative%20relationship
• https://www.aanp.org/advocacy/texas#:~:text=Regulatory%20Structure
• https://www.flanp.org/page/PastNewLaws#:~:text=must%20engage%20in%20such%20practice,is%20composed%20of%209%20members
• https://texasnp.org/news-laws-and-regulations/#:~:text=,or%20before%20November%2011%2C%202023
• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20,controlled%20substances%20like%20Adderall%20without
• https://www.leginfo.legislature.ca.gov/faces/billTextClient.xhtml?bill_id=201920200AB890#:~:text=education%2C%20experience%2C%20and%20certification%20requirements,The%20bill%20would%20require%20the
• https://www.icanotes.com/2022/03/09/telehealth-parity-laws/#:~:text=reports%20that%2044%20states%2C%20the,or%20limitations%20in%20their%20implementation
• https://payerprice.com/rates/99214-CPT-fee-schedule#:~:text=National%20average%20reimbursement%20for%20CPT,99214%20by%20major%20payers
• https://www.healingpsychiatryflorida.com/blogs/psychiatrist-shortage-by-state/#:~:text=42%20%20,9%2C318
• https://www.healingpsychiatryflorida.com/blogs/psychiatrist-shortage-by-state/#:~:text=43%20%20,9%2C327